Abstract:We have demonstrated that exogenous hydrogen sulfide (H2S) protects H9c2 cardiac cells against the doxorubicin (DOX)-induced injuries by inhibiting p38 mitogen-activated protein kinase (MAPK) pathway and that the p38 MAPK/nuclear factor-κB (NF-κB) pathway is involved in the DOX-induced inflammatory response and cytotoxicity. The present study attempts to test the hypothesis that exogenous H2S might protect cardiomyocytes against the DOX-induced inflammation and cytotoxicity through inhibiting p38 MAPK/NF-κB pathway.H9c2 cardiac cells were exposed to 5μM DOX for 24 h to establish a model of DOX cardiotoxicity. The cells were pretreated with NaHS( a donor of H2S) or other drugs before exposure to DOX. Cell viability was analyzed by cell counter kit 8 ( CCK-8), The expression of NF-κB p65 and inducible nitric oxide synthase (iNOS) was detected by Western blot assay. The levels of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) were tested by enzyme-linked immunosorbent assay (ELISA).Our findings demonstrated that pretreatment of H9c2 cardiac cells with NaHS for 30 min before exposure to DOX markedly ameliorated the DOX-induced phosphorylation and nuclear translocation of NF-κB p65 subunit. Importantly, the pretreatment with NaHS significantly attenuated the p38 MAPK/NF-κB pathway-mediated inflammatory responses induced by DOX, as evidenced by decreases in the levels of IL-1β, IL-6 and TNF-α. In addition, application of NaHS or IL-1β receptor antagonist (IL-1Ra) or PDTC (an inhibitor of NF-κB) attenuated the DOX-induced expression of iNOS and production of nitric oxide (NO), respectively. Furthermore, IL-1Ra also dramatically reduced the DOX-induced cytotoxicity and phosphorylation of NF-κB p65. The pretreatment of H9c2 cells with N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS) prior to exposure to DOX depressed the phosphorylation of NF-κB p65 induced by DOX.The present study has demonstrated the new mechanistic evidence that exogenous H2S attenuates the DOX-induced inflammation and cytotoxicity by inhibiting p38 MAPK/NF-κB pathway in H9c2 cardiac cells. We also provide novel data that the interaction between NF-κB pathway and IL-1β is important in the induction of DOX-induced inflammation and cytotoxicity in H9c2 cardiac cells.

Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition.

Hydrogen Sulfide Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Apoptosis by Preventing GSK-3beta-dependent Opening of Mptp.

Hydrogen Sulfide Attenuates the Recruitment of CD11b + Gr-1 + Myeloid Cells and Regulates Bax/Bcl-2 Signaling in Myocardial Ischemia Injury

Hydrogen Sulfide Protects Against Apoptosis under Oxidative Stress Through Sirt1 Pathway in H9c2 Cardiomyocytes

Hydrogen Sulfide Contributes to Cardioprotection During Ischemia-Reperfusion Injury by Opening K-Atp Channels

Hydrogen Sulfide Alleviates Acute Myocardial Ischemia Injury by Modulating Autophagy and Inflammation Response under Oxidative Stress

Hydrogen Sulfide Improves Cardiomyocytes Electrical Remodeling Post Ischemia/reperfusion Injury in Rats.

Hydrogen Sulfide Attenuates Cardiac Dysfunction in a Rat Model of Heart Failure: a Mechanism Through Cardiac Mitochondrial Protection

Exogenous Hydrogen Sulfide Protects Against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting P38mapk/nf&#954;b Pathway in H9c2 Cardiac Cells

Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion.

Hydrogen Sulfide Alleviates Cardiac Contractile Dysfunction in an Akt2-knockout Murine Model of Insulin Resistance: Role of Mitochondrial Injury and Apoptosis.

Endogenous Hydrogen Sulfide Regulation of Myocardial Injury Induced by Isoproterenol.

Exogenous hydrogen sulfide restores cardioprotection of ischemic post-conditioning via inhibition of mPTP opening in the aging cardiomyocytes.

Exogenous H2S Contributes to Recovery of Ischemic Post-Conditioning-induced Cardioprotection by Decrease of ROS Level Via Down-Regulation of NF-κB and JAK2-STAT3 Pathways in the Aging Cardiomyocytes

Hydrogen Sulfide‐induced Apoptosis of Human Aorta Smooth Muscle Cells Via the Activation of Mitogen‐activated Protein Kinases and Caspase‐3

Exogenous Hydrogen Sulfide Attenuates Diabetic Myocardial Injury Through Cardiac Mitochondrial Protection

Hydrogen Sulfide Restores Cardioprotective Effects of Remote Ischemic Preconditioning in Aged Rats Via HIF-1α/Nrf2 Signaling Pathway

Hydrogen Sulfide Protects Against Myocardial Ischemia and Reperfusion Injury by Activating AMP-activated Protein Kinase to Restore Autophagic Flux.

A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects Against Myocardial Ischemia/Reperfusion Injury

Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway

Protective Effects Of Hydrogen Sulfide In Hypoxic Human Umbilical Vein Endothelial Cells: A Possible Mitochondria-Dependent Pathway